This protocol covers the specific scenario of constrictive pericarditis presenting alongside active pericardial inflammation — where evidence of concomitant pericarditis is established by clinical criteria, biomarkers, and/or imaging.
Constrictive pericarditis with concomitant pericarditis is characterised by pericardial constriction in the setting of demonstrable pericardial inflammation. Confirmation requires evidence of active pericarditis through clinical criteria, biochemical biomarkers, and/or imaging findings. This combination defines a distinct subgroup in whom a targeted anti-inflammatory strategy is specifically indicated.
Management centres on empiric anti-inflammatory therapy. The specific agents involved, the recommended duration, and the full clinical algorithm are detailed in the complete protocol — accessible below.
Clinical remission after therapy, with normalisation of imaging findings and resolution of pericardial constriction.
DOI: 10.1093/eurheartj/ehaf192